chuka_lis: (Default)
[personal profile] chuka_lis
Эскспериментальное лечение моноклональными антителами от Регенерона тяжелых ковидных больных остановлено в США- из соображений безопасности.
Regeneron said it is pausing enrollment of hospitalized COVID-19 patients receiving mechanical ventilation or intense oxygen after the independent monitoring committee observed “a potential safety signal and an unfavorable risk/benefit profile at this time.”

The monitoring board recommended collecting additional data on the patients already enrolled.

Earlier this month, a different monitoring board recommended pausing enrollment in a study testing an Eli Lilly antibody drug to investigate a possible safety issue in hospitalized patients.

NIAID Director Anthony FauciListening to experts isn't perfect, but ignoring them is far worse Fauci: Maybe 2022 before US sees 'some semblances of normality' Fauci expresses support for national mask mandate MORE this week said treatment is all about timing; dexamethasone and other steroids can help with severely ill patients on ventilation, as can the antiviral drug remdesivir. Studies with experimental antibody treatments, on the other hand, suggest they are most effective when given on an outpatient basis to someone with mild symptoms
Будем ждать подробностей.
This account has disabled anonymous posting.
If you don't have an account you can create one now.
HTML doesn't work in the subject.
More info about formatting

Profile

chuka_lis: (Default)
chuka_lis

June 2025

M T W T F S S
      1
2 3 4 5 6 78
9 1011 1213 1415
16171819202122
23242526272829
30      

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated Jun. 16th, 2025 02:14 am
Powered by Dreamwidth Studios